910235-65-3

Basic information

• Product Name: N-[2-Methyl-3-(4,4,5,5-tetraMethyl[1,3,2]dioxaborolan-2-yl)phenyl]-4-(tert-butyl)benzaMide
• Synonyms: N-[2-Methyl-3-(4,4,5,5-tetraMethyl[1,3,2]dioxaborolan-2-yl)phenyl]-4-(tert-butyl)benzaMide;4-(tert-butyl)-N-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide
• CAS NO: 910235-65-3
• Molecular Formula: C₂₄H₃₂BNO₃
• Molecular Weight: 393.32678
• Mol File: 910235-65-3.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-[2-Methyl-3-(4,4,5,5-tetraMethyl[1,3,2]dioxaborolan-2-yl)phenyl]-4-(tert-butyl)benzaMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-Methyl-3-(4,4,5,5-tetraMethyl[1,3,2]dioxaborolan-2-yl)phenyl]-4-(tert-butyl)benzaMide(910235-65-3)
• EPA Substance Registry System: N-[2-Methyl-3-(4,4,5,5-tetraMethyl[1,3,2]dioxaborolan-2-yl)phenyl]-4-(tert-butyl)benzaMide(910235-65-3)

Safety Data

• Hazardous Substances Data: 910235-65-3(Hazardous Substances Data)

Upstream product

• 591-19-5 m-Bromoaniline 
• 304672-89-7 N-(3-bromophenyl)-4-(tert-butyl)benzamide 
• 73183-34-3 bis(pinacol)diborane 
• 98-73-7 4-(1,1-dimethylethyl)benzoic acid 
• 910235-64-2 2-(2-methyl-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 55289-35-5 2-bromo-6-nitrotoluene 
• 1710-98-1 p-tert-butyl benzoyl chloride 
• 1013116-83-0 N-(3-bromo-2-methylphenyl)-4-(tert-butyl)benzamide 
• 882678-96-8 2-methyl-3-( 4,4,5,5-tetramethyl[1,3,2]dioxaborolane-2-yl)phenylamine 

Downstream Products

• 910235-66-4 4-{5-[3-(4-tert-butyl-benzoylamino)-2-methylphenyl]-1-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino}-benzoic acid ethyl ester 
• 910232-85-8 4-{6-[3-(4-tert-butyl-benzoylamino)-2-methyl-phenyl]-4-methyl-3-oxo-3,4-dihydro-pyrazin-2-ylamino}-benzoic acid ethyl ester 
• 910235-69-7 4-tert-butyl-N-{3-[6-(4-fluoro-3-nitro-phenylamino)-4-methyl-5-oxo-4,5-dihydro-pyrazin-2-yl]-2-methyl-phenyl}-benzamide 
• 910235-77-7 4-tert-butyl-N-{3-[6-(4-formyl-phenylamino)-4-methyl-5-oxo-4,5-dihydro-pyrazin-2-yl]-2-methyl-phenyl}-benzamide 
• 910235-79-9 4-tert-butyl-N-(3-{6-[4-(2-hydroxy-ethyl)-phenylamino]-4-methyl-5-oxo-4,5-dihydro-pyrazin-2-yl}-2-methyl-phenyl)-benzamide 
• 1147530-73-1 7-tert-butyl-3-[2-methyl-3-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenyl]-3H-quinazolin-4-one 
• 1147529-04-1 4-tert-butyl-N-{2-methyl-3-[1-methyl-5-(2-methylsulfanyl-pyrimidin-4-ylamino)-6-oxo-1,6-dihydro-pyridazin-3-yl]-phenyl}-benzamide 
• 1147528-82-2 4-tert-butyl-N-(2-methyl-3-{1-methyl-5-[5-(morpholine-4-carbonyl)pyridin-2-ylamino]-6-oxo-1,6-dihydropyridazin-3-yl}phenyl)benzamide 
• 1147530-74-2 C₂₂H₂₄N₄O₂ 
• 1161846-71-4 4-tert-butyl-N-{2-methyl-3-[8-({5-[(morpholin-4-yl)carbonyl]pyridin-2-yl}amino)imidazo[1,2-a]pyridin-6-yl]phenyl}benzamide 
• 910232-70-1 4-[(5-{3-[(4-tert-butylbenzene)amido]-2-methylphenyl}-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)amino]benzoic acid 
• 910232-69-8 4-tert-butyl-N-(2-methyl-3-{1-methyl-5-[4-(morpholine-4-carbonyl)phenylamino]-6-oxo-1,6-dihydropyridin-3-yl}phenyl)benzamide 
• 886854-77-9 4-tert-butyl-N-(2-methyl-3-{8-[4-(morpholine-4-carbonyl)phenylamino]imidazo[1,2-a]pyrazin-6-yl}phenyl)benzamide 
• 852221-24-0 4-{6-[3-(4-tert-butylbenzoylamino)-2-methylphenyl]imidazo[1,2-a]pyrazin-8-ylamino}benzoic acid 

Relevant articles and documents

Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitors

Bruton's tyrosine kinase (BTK) is a cytoplasmic, non-receptor tyrosine kinase member of the TEC family of tyrosine kinases. Pre-clinical and clinical data have shown that targeting BTK can be used for the treatment for B-cell disorders. Here we disclose t

Pyrrolopyrimidine BTK inhibitor as well as preparation method and application thereof

The invention provides a pyrrolopyrimidine BTK inhibitor as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The compound has the structural general formula shown in a formula (I). In-flight

NOVEL IRREVERSIBLE BRUTON'S TYROSINE KINASE INHIBITOR

The present invention provides an inhibitor of Bruton's tyrosine kinase, which is a compound of formula (I), or its pharmaceutically acceptable salt, solvate, ester, acid, metabolite or prodrug. The present invention also provides a pharmaceutical composition comprsing the compound. The present invention also provides a method for inhibiting the activity of tyrosine kinase activity or for treating a disease, disorder, or condition, which would benefit from the inhibition of Bruton's tyrosine kinase(s), by using the Bruton's tyrosine kinase inhibitor, as well as application of the Bruton's tyrosine kinase inhibitor for the same.